Sana Biotechnology, Inc. financial data

Symbol
SANA on Nasdaq
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 280% % -43%
Debt-to-equity 141% % 61%
Return On Equity -142% % -67%
Return On Assets -59% % -30%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 266,866,897 shares 19%
Common Stock, Shares, Outstanding 266,732,000 shares 19%
Entity Public Float $295,100,000 USD -50%
Common Stock, Value, Issued $27,000 USD 23%
Weighted Average Number of Shares Outstanding, Basic 253,234,000 shares 9.7%
Weighted Average Number of Shares Outstanding, Diluted 253,234,000 shares 9.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $131,980,000 USD -39%
General and Administrative Expense $44,296,000 USD -31%
Operating Income (Loss) $250,319,000 USD 8.2%
Net Income (Loss) Attributable to Parent $244,166,000 USD 8.5%
Earnings Per Share, Basic -0.96 USD/shares 17%
Earnings Per Share, Diluted -0.96 USD/shares 17%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $71,870,000 USD -44%
Marketable Securities, Current $66,512,000 USD 167%
Assets, Current $148,676,000 USD -7.5%
Property, Plant and Equipment, Net $26,906,000 USD -65%
Operating Lease, Right-of-Use Asset $38,313,000 USD -34%
Intangible Assets, Net (Excluding Goodwill) $59,195,000 USD 0%
Goodwill $140,627,000 USD 0%
Other Assets, Noncurrent $3,173,000 USD -38%
Assets $416,890,000 USD -17%
Accounts Payable, Current $1,669,000 USD -68%
Employee-related Liabilities, Current $13,240,000 USD -8.4%
Liabilities, Current $78,726,000 USD 73%
Operating Lease, Liability, Noncurrent $63,924,000 USD -22%
Other Liabilities, Noncurrent $10,600,000 USD 7.1%
Liabilities $256,006,000 USD 2.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $28,000 USD 100%
Retained Earnings (Accumulated Deficit) $1,849,016,000 USD -15%
Stockholders' Equity Attributable to Parent $160,884,000 USD -36%
Liabilities and Equity $416,890,000 USD -17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $48,657,000 USD 26%
Net Cash Provided by (Used in) Financing Activities $982,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $16,603,000 USD
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 266,732,000 shares 19%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $31,072,000 USD -171%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $76,065,000 USD -42%
Deferred Tax Assets, Valuation Allowance $507,814,000 USD 13%
Deferred Tax Assets, Gross $517,644,000 USD 11%
Operating Lease, Liability $78,862,000 USD -16%
Depreciation $12,800,000 USD -17%
Payments to Acquire Property, Plant, and Equipment $136,000 USD -99%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $244,152,000 USD 8.4%
Lessee, Operating Lease, Liability, to be Paid $119,332,000 USD -31%
Property, Plant and Equipment, Gross $81,661,000 USD -38%
Operating Lease, Liability, Current $14,938,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year Two $19,390,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One $22,473,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.109 pure -5.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $40,470,000 USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year Three $14,698,000 USD -24%
Deferred Tax Assets, Operating Loss Carryforwards $299,757,000 USD 32%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,071,000 USD -4.3%
Additional Paid in Capital $2,009,845,000 USD 8.3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $9,830,000 USD -33%
Share-based Payment Arrangement, Expense $25,464,000 USD -32%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%